Noxxon Pharma
Noxxon Pharma develops biostable aptamers and substances based on mirror image nucleic acids.
Noxxon Pharma has raised €35M across 2 funding rounds, most recently a round in Oct 2010. Based in Berlin, Germany; founded 2007; active in Media. Data as of 28 Oct 2026.
Total raised
€35M
€35,000,000
Funding rounds
2
Investors
0
distinct backers
Active since
2010-05
latest 2010-10
Funding by year
EUR raised per yearNoxxon Pharma — funding by year — interactive chart.
Data table
| Noxxon Pharma — funding by year | |
|---|---|
| 2010 | €35M |
Signals
Medium confidenceRaise-next likelihood5
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Down/flat last round
Exit likelihood6
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▼ Old (19y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2010-10-01 | Other | €2.0M | — | View deal → |
| 2010-05-01 | Other | €33M | — | View deal → |
Similar companies
same sector or countryGlobal coverage: FundingData